- Published on
Infectious disease and microbiology – Otitis externa
Otitis externa is an infection of the external auditory canal and is classified into four main types: acute localized, acute diffuse (swimmer’s ear), chronic, and invasive (malignant or necrotizing) otitis externa, the latter being a severe form that extends beyond the ear canal into surrounding soft tissue and bone. While most forms are common—affecting approximately 4 per 1000 people annually—the invasive form is rare but potentially life-threatening.
Risk factors vary by type. Hot, humid climates, frequent water exposure, and mechanical trauma (e.g., scratching or use of cotton swabs) predispose to acute diffuse otitis externa. In contrast, elderly patients, diabetics, and immunocompromised individuals are at higher risk for the invasive form. Preventive strategies include avoiding trauma to the ear canal and maintaining good diabetic control.
Pathophysiologically, disruption of the ear canal’s natural defenses—such as reduced acidity or decreased antimicrobial components like lysozyme and immunoglobulins (IgA, IgG)—facilitates microbial growth. Pseudomonas aeruginosa plays a key role, particularly in invasive disease, through increased expression of virulence factors such as exotoxins.
The etiology depends on the subtype. Acute localized infections (furuncles) are typically caused by Staphylococcus aureus. Acute diffuse otitis externa is most commonly due to Pseudomonas aeruginosa, along with other gram-negative bacteria, S. aureus, and occasionally fungi like Aspergillus. Chronic otitis externa is often related to persistent irritation from middle ear infections. Invasive otitis externa is most frequently caused by P. aeruginosa (>95% of cases), though other bacteria and fungi may be involved.
Clinically, patients with acute disease present with ear pain (otalgia), itching (pruritus), and sometimes discharge, with pain often worsened by manipulation of the auricle. Chronic cases tend to cause itching rather than pain. Invasive otitis externa presents more severely, with intense pain, purulent drainage, granulation tissue in the ear canal, and possible cranial nerve involvement (especially facial nerve palsy).
Diagnosis is primarily clinical and relies heavily on otoscopic examination. In invasive disease, laboratory findings may show a normal white blood cell count but elevated erythrocyte sedimentation rate. Imaging with CT (for bone involvement) and MRI (for soft tissue extension) is essential to assess disease extent. Deep tissue biopsy may be required to confirm diagnosis and exclude malignancy.
Treatment depends on severity. Topical antibiotic drops (often combined with corticosteroids) are the mainstay for uncomplicated cases, along with ear canal cleaning and moisture avoidance. Oral antibiotics are used if local therapy fails. Invasive otitis externa requires prolonged intravenous antipseudomonal antibiotics (6–8 weeks) such as ciprofloxacin, ceftazidime, cefepime, or carbapenems, along with meticulous canal care. Antifungal therapy is indicated when fungal pathogens are identified.
The prognosis is generally excellent for uncomplicated cases. In invasive otitis externa, outcomes have improved significantly, with up to 95% cure rates, although prognosis worsens with cranial nerve involvement, fungal infection, bilateral disease, or underlying immunosuppression.
Complications of invasive disease can be severe and include spread to the skull base, cranial nerve palsies, sigmoid sinus thrombosis, meningitis, and brain infection, making early recognition and aggressive treatment critical.
Otitis externa is an infection of the external auditory canal and is classified into four main types: acute localized, acute diffuse (swimmer’s ear), chronic, and invasive (malignant or necrotizing) otitis externa, the latter being a severe form that extends beyond the ear canal into surrounding soft tissue and bone. While most forms are common—affecting approximately 4 per 1000 people annually—the invasive form is rare but potentially life-threatening.
Risk factors vary by type. Hot, humid climates, frequent water exposure, and mechanical trauma (e.g., scratching or use of cotton swabs) predispose to acute diffuse otitis externa. In contrast, elderly patients, diabetics, and immunocompromised individuals are at higher risk for the invasive form. Preventive strategies include avoiding trauma to the ear canal and maintaining good diabetic control.
Pathophysiologically, disruption of the ear canal’s natural defenses—such as reduced acidity or decreased antimicrobial components like lysozyme and immunoglobulins (IgA, IgG)—facilitates microbial growth. Pseudomonas aeruginosa plays a key role, particularly in invasive disease, through increased expression of virulence factors such as exotoxins.
The etiology depends on the subtype. Acute localized infections (furuncles) are typically caused by Staphylococcus aureus. Acute diffuse otitis externa is most commonly due to Pseudomonas aeruginosa, along with other gram-negative bacteria, S. aureus, and occasionally fungi like Aspergillus. Chronic otitis externa is often related to persistent irritation from middle ear infections. Invasive otitis externa is most frequently caused by P. aeruginosa (>95% of cases), though other bacteria and fungi may be involved.
Clinically, patients with acute disease present with ear pain (otalgia), itching (pruritus), and sometimes discharge, with pain often worsened by manipulation of the auricle. Chronic cases tend to cause itching rather than pain. Invasive otitis externa presents more severely, with intense pain, purulent drainage, granulation tissue in the ear canal, and possible cranial nerve involvement (especially facial nerve palsy).
Diagnosis is primarily clinical and relies heavily on otoscopic examination. In invasive disease, laboratory findings may show a normal white blood cell count but elevated erythrocyte sedimentation rate. Imaging with CT (for bone involvement) and MRI (for soft tissue extension) is essential to assess disease extent. Deep tissue biopsy may be required to confirm diagnosis and exclude malignancy.
Treatment depends on severity. Topical antibiotic drops (often combined with corticosteroids) are the mainstay for uncomplicated cases, along with ear canal cleaning and moisture avoidance. Oral antibiotics are used if local therapy fails. Invasive otitis externa requires prolonged intravenous antipseudomonal antibiotics (6–8 weeks) such as ciprofloxacin, ceftazidime, cefepime, or carbapenems, along with meticulous canal care. Antifungal therapy is indicated when fungal pathogens are identified.
The prognosis is generally excellent for uncomplicated cases. In invasive otitis externa, outcomes have improved significantly, with up to 95% cure rates, although prognosis worsens with cranial nerve involvement, fungal infection, bilateral disease, or underlying immunosuppression.
Complications of invasive disease can be severe and include spread to the skull base, cranial nerve palsies, sigmoid sinus thrombosis, meningitis, and brain infection, making early recognition and aggressive treatment critical.
- Published on
Infectious disease and microbiology – Osteomyelitis
Osteomyelitis is an infection of bone, most commonly caused by bacteria and only rarely by fungi. It may present as acute disease, developing over days to weeks, or as chronic osteomyelitis, which evolves over months or years and is often associated with necrotic bone (sequestrum). The condition has an estimated incidence of 10–100 cases per 100,000 population and arises in a variety of clinical settings depending on host factors and route of infection.
Several risk factors predispose individuals to osteomyelitis, including diabetes mellitus (especially with foot ulcers), intravenous drug use, peripheral vascular disease, trauma, immunosuppression, and prior surgery or prosthetic implants. Certain organisms are associated with specific populations—for example, Salmonella in patients with sickle cell disease and Pseudomonas aeruginosa in intravenous drug users or puncture wounds through footwear. Preventive strategies emphasize good diabetic foot care and maintaining sterile surgical conditions, particularly for prosthetic procedures.
Infection reaches bone through three principal mechanisms: hematogenous spread, direct inoculation (trauma or surgery), or contiguous spread from nearby infected tissues. Once established, infection can involve the cortex, medullary cavity, and periosteum, leading to inflammation, abscess formation, and eventual bone necrosis. In children, infection commonly affects the metaphysis of long bones, whereas in adults, vertebral involvement is more typical.
The etiology is broad, with Staphylococcus aureus being the most common pathogen overall. Other causes include gram-negative organisms (e.g., Enterobacteriaceae), Pseudomonas, coagulase-negative staphylococci (especially in prosthetic infections), Mycobacterium tuberculosis, fungi such as Candida or endemic mycoses, and less commonly Brucella or organisms related to travel exposures.
Clinically, patients often present with localized bone pain, fever, swelling, and warmth over the affected area. Chronic cases may feature sinus tract formation with drainage. Recurrent or persistent cellulitis over a bony area should raise suspicion for underlying osteomyelitis. Diagnosis relies on a combination of laboratory testing and imaging, but the gold standard is bone biopsy for culture and histopathology, ideally obtained before antibiotic therapy. Blood cultures may identify the organism in up to 40% of acute cases, while inflammatory markers such as ESR are useful for monitoring disease activity.
Imaging plays a crucial role: plain X-rays may initially be normal, while MRI is highly sensitive, especially for spinal disease. CT scans can detect early cortical changes, and radionuclide scans are useful for early detection and identifying multifocal involvement. Advanced imaging such as PET may be helpful in chronic or unclear cases.
Management requires a combined medical and surgical approach. Prolonged antibiotic therapy (typically ≥6 weeks) is essential and should be tailored to the identified organism. For example, methicillin-susceptible S. aureus is treated with nafcillin or oxacillin, while MRSA requires vancomycin or alternative agents. Gram-negative infections are treated with fluoroquinolones or third-generation cephalosporins, and Pseudomonas infections require antipseudomonal agents. Importantly, surgical debridement of necrotic bone is often necessary, especially in chronic disease, and removal of infected prosthetic material may be required.
The prognosis is generally good for acute osteomyelitis with timely treatment but more guarded in chronic cases, where recurrence is common. Complications can be severe and include bone destruction, pathological fractures, epidural abscess with spinal cord compression, cranial neuropathies (in skull base involvement), amyloidosis, and even malignant transformation (Marjolin’s ulcer). Long-term follow-up is essential, as clinical and radiologic resolution may lag behind actual disease control.
Osteomyelitis is an infection of bone, most commonly caused by bacteria and only rarely by fungi. It may present as acute disease, developing over days to weeks, or as chronic osteomyelitis, which evolves over months or years and is often associated with necrotic bone (sequestrum). The condition has an estimated incidence of 10–100 cases per 100,000 population and arises in a variety of clinical settings depending on host factors and route of infection.
Several risk factors predispose individuals to osteomyelitis, including diabetes mellitus (especially with foot ulcers), intravenous drug use, peripheral vascular disease, trauma, immunosuppression, and prior surgery or prosthetic implants. Certain organisms are associated with specific populations—for example, Salmonella in patients with sickle cell disease and Pseudomonas aeruginosa in intravenous drug users or puncture wounds through footwear. Preventive strategies emphasize good diabetic foot care and maintaining sterile surgical conditions, particularly for prosthetic procedures.
Infection reaches bone through three principal mechanisms: hematogenous spread, direct inoculation (trauma or surgery), or contiguous spread from nearby infected tissues. Once established, infection can involve the cortex, medullary cavity, and periosteum, leading to inflammation, abscess formation, and eventual bone necrosis. In children, infection commonly affects the metaphysis of long bones, whereas in adults, vertebral involvement is more typical.
The etiology is broad, with Staphylococcus aureus being the most common pathogen overall. Other causes include gram-negative organisms (e.g., Enterobacteriaceae), Pseudomonas, coagulase-negative staphylococci (especially in prosthetic infections), Mycobacterium tuberculosis, fungi such as Candida or endemic mycoses, and less commonly Brucella or organisms related to travel exposures.
Clinically, patients often present with localized bone pain, fever, swelling, and warmth over the affected area. Chronic cases may feature sinus tract formation with drainage. Recurrent or persistent cellulitis over a bony area should raise suspicion for underlying osteomyelitis. Diagnosis relies on a combination of laboratory testing and imaging, but the gold standard is bone biopsy for culture and histopathology, ideally obtained before antibiotic therapy. Blood cultures may identify the organism in up to 40% of acute cases, while inflammatory markers such as ESR are useful for monitoring disease activity.
Imaging plays a crucial role: plain X-rays may initially be normal, while MRI is highly sensitive, especially for spinal disease. CT scans can detect early cortical changes, and radionuclide scans are useful for early detection and identifying multifocal involvement. Advanced imaging such as PET may be helpful in chronic or unclear cases.
Management requires a combined medical and surgical approach. Prolonged antibiotic therapy (typically ≥6 weeks) is essential and should be tailored to the identified organism. For example, methicillin-susceptible S. aureus is treated with nafcillin or oxacillin, while MRSA requires vancomycin or alternative agents. Gram-negative infections are treated with fluoroquinolones or third-generation cephalosporins, and Pseudomonas infections require antipseudomonal agents. Importantly, surgical debridement of necrotic bone is often necessary, especially in chronic disease, and removal of infected prosthetic material may be required.
The prognosis is generally good for acute osteomyelitis with timely treatment but more guarded in chronic cases, where recurrence is common. Complications can be severe and include bone destruction, pathological fractures, epidural abscess with spinal cord compression, cranial neuropathies (in skull base involvement), amyloidosis, and even malignant transformation (Marjolin’s ulcer). Long-term follow-up is essential, as clinical and radiologic resolution may lag behind actual disease control.
- Published on
Infectious disease and microbiology – Mumps
Mumps is a viral infection primarily affecting children, characterized by painful swelling of the parotid glands. Although usually mild and self-limited, it can lead to complications such as orchitis, pancreatitis, and aseptic meningitis, especially in adults.
The disease occurs worldwide and is caused by an enveloped RNA virus from the Paramyxoviridae family (genus Rubulavirus). Transmission occurs through direct contact with respiratory secretions of infected individuals.
Mumps most commonly affects children aged 5–9 years, although about one-third of cases occur in individuals older than 15 years. Widespread vaccination programs have significantly reduced incidence, particularly in developed countries. However, outbreaks can still occur, especially in crowded settings such as college campuses, even among vaccinated populations.
The incubation period ranges from 14 to 21 days, and up to 30–40% of infections may be asymptomatic. Symptomatic patients typically present with fever, malaise, headache, and painful swelling of the parotid glands, which develops within the first few days. Swelling is often bilateral and may be worsened by eating sour foods. Symptoms usually resolve within one week.
On physical examination, parotid enlargement leads to obliteration of the mandibular angle and upward displacement of the ear. Other salivary glands may occasionally be involved.
Complications can occur, particularly in post-pubertal individuals.
Orchitis affects up to 30% of post-pubertal males, presenting with testicular pain, swelling, and fever.
In females, oophoritis and mastitis may occur.
Aseptic meningitis is relatively common but typically self-limited.
Other complications include transient hearing loss, pancreatitis, and rarely encephalitis.
Diagnosis is usually clinical, based on characteristic features. Laboratory findings may include leukopenia and elevated serum amylase.
Confirmation can be achieved with serologic testing (IgM/IgG ELISA) or PCR detection of viral RNA from saliva, cerebrospinal fluid, or urine.
There is no specific antiviral treatment for mumps. Management is supportive and includes rest, hydration, and analgesics.
In cases of orchitis, additional measures such as scrotal elevation, cold compresses, and NSAIDs are recommended.
Prevention relies on vaccination, typically given as part of the MMR (measles–mumps–rubella) vaccine, administered in childhood with two doses. Isolation of infected individuals for 5 days after onset of parotitis helps limit transmission.
The prognosis is generally excellent, with lifelong immunity after infection.
Complications are uncommon but may include testicular atrophy, reduced sperm counts, hearing loss, encephalitis, and, rarely, permanent neurologic damage.
In pregnancy, mumps infection has been associated with fetal complications, including low birth weight and fetal loss.
Mumps is a viral infection primarily affecting children, characterized by painful swelling of the parotid glands. Although usually mild and self-limited, it can lead to complications such as orchitis, pancreatitis, and aseptic meningitis, especially in adults.
The disease occurs worldwide and is caused by an enveloped RNA virus from the Paramyxoviridae family (genus Rubulavirus). Transmission occurs through direct contact with respiratory secretions of infected individuals.
Mumps most commonly affects children aged 5–9 years, although about one-third of cases occur in individuals older than 15 years. Widespread vaccination programs have significantly reduced incidence, particularly in developed countries. However, outbreaks can still occur, especially in crowded settings such as college campuses, even among vaccinated populations.
The incubation period ranges from 14 to 21 days, and up to 30–40% of infections may be asymptomatic. Symptomatic patients typically present with fever, malaise, headache, and painful swelling of the parotid glands, which develops within the first few days. Swelling is often bilateral and may be worsened by eating sour foods. Symptoms usually resolve within one week.
On physical examination, parotid enlargement leads to obliteration of the mandibular angle and upward displacement of the ear. Other salivary glands may occasionally be involved.
Complications can occur, particularly in post-pubertal individuals.
Orchitis affects up to 30% of post-pubertal males, presenting with testicular pain, swelling, and fever.
In females, oophoritis and mastitis may occur.
Aseptic meningitis is relatively common but typically self-limited.
Other complications include transient hearing loss, pancreatitis, and rarely encephalitis.
Diagnosis is usually clinical, based on characteristic features. Laboratory findings may include leukopenia and elevated serum amylase.
Confirmation can be achieved with serologic testing (IgM/IgG ELISA) or PCR detection of viral RNA from saliva, cerebrospinal fluid, or urine.
There is no specific antiviral treatment for mumps. Management is supportive and includes rest, hydration, and analgesics.
In cases of orchitis, additional measures such as scrotal elevation, cold compresses, and NSAIDs are recommended.
Prevention relies on vaccination, typically given as part of the MMR (measles–mumps–rubella) vaccine, administered in childhood with two doses. Isolation of infected individuals for 5 days after onset of parotitis helps limit transmission.
The prognosis is generally excellent, with lifelong immunity after infection.
Complications are uncommon but may include testicular atrophy, reduced sperm counts, hearing loss, encephalitis, and, rarely, permanent neurologic damage.
In pregnancy, mumps infection has been associated with fetal complications, including low birth weight and fetal loss.
- Published on
Infectious Disease and Microbiology - Mediastinitis
Mediastinitis is a serious infection involving the mediastinum, the central compartment of the thoracic cavity. It may present as acute or chronic disease. Acute mediastinitis is a life-threatening condition often resulting from esophageal perforation, cardiothoracic surgery, trauma, or spread from nearby infections such as those of the head and neck. A particularly severe form is descending necrotizing mediastinitis, where infection spreads rapidly from the oropharynx into the chest. Chronic mediastinitis is less common and is typically associated with granulomatous diseases such as tuberculosis or histoplasmosis, or with retained foreign bodies.
Currently, most cases of mediastinitis occur as complications following cardiac surgery, especially after sternotomy. The incidence of post-surgical mediastinitis ranges from approximately 0.4% to 5%. Despite advances in surgical techniques and infection control, the incidence has remained stable due to increasing numbers of elderly and immunocompromised patients undergoing complex procedures. Risk factors include diabetes mellitus, obesity, chronic lung disease, prolonged surgical time, reoperation, and vascular comorbidities.
The pathophysiology involves invasion of the mediastinum by pathogens, leading to intense inflammation, fibrin deposition, and formation of abscesses. Infection can spread rapidly through fascial planes, creating extensive tissue damage and dead space beneath the sternum. Acute infections are usually polymicrobial. Common organisms include gram-positive bacteria such as Staphylococcus aureus and Staphylococcus epidermidis in post-surgical cases, while infections related to esophageal or oropharyngeal sources often involve gram-negative and anaerobic organisms. In severely ill patients, fungal pathogens like Candida and Aspergillus may also be involved.
Clinically, acute mediastinitis presents with fever, severe chest pain, dysphagia, and respiratory distress. Patients with esophageal perforation may also have epigastric pain. Physical findings can include a sternal click (indicating instability), crepitus due to subcutaneous air, and Hamman’s sign, a crunching sound heard over the chest. In contrast, chronic mediastinitis may initially be asymptomatic but later presents with symptoms due to compression of mediastinal structures, such as cough, dyspnea, or signs of superior vena cava syndrome.
Laboratory findings typically show leukocytosis and elevated inflammatory markers such as C-reactive protein. Blood cultures may be positive, especially in cases associated with head and neck infections. Imaging is essential for diagnosis. Chest radiographs may reveal mediastinal widening or air-fluid levels, while CT scans provide detailed visualization of fluid collections, gas, and the extent of infection. Diagnostic procedures such as CT-guided aspiration, mediastinoscopy, or thoracoscopy may be required to obtain microbiological samples.
Management of mediastinitis requires urgent and aggressive treatment. Broad-spectrum intravenous antibiotics should be initiated promptly and later tailored based on culture results. Common regimens include combinations of cephalosporins with anaerobic coverage or agents such as piperacillin-tazobactam. Coverage for MRSA may require vancomycin or linezolid. Therapy is typically prolonged, lasting several weeks.
Surgical intervention is critical and remains the cornerstone of treatment. Procedures include drainage of infected material, debridement of necrotic tissue, and sometimes more extensive approaches such as thoracotomy or video-assisted thoracic surgery. Negative pressure wound therapy may be used in postoperative cases. Supportive care, including airway management, oxygen therapy, and adequate nutrition, is essential.
The prognosis of mediastinitis is guarded, with mortality rates reaching up to 50%, especially in delayed or inadequately treated cases. Early diagnosis and prompt surgical drainage significantly improve outcomes. Complications can be severe and include sepsis, pleural empyema, sternal osteomyelitis, acute respiratory distress syndrome, thrombosis, and superior vena cava syndrome.
Mediastinitis is a serious infection involving the mediastinum, the central compartment of the thoracic cavity. It may present as acute or chronic disease. Acute mediastinitis is a life-threatening condition often resulting from esophageal perforation, cardiothoracic surgery, trauma, or spread from nearby infections such as those of the head and neck. A particularly severe form is descending necrotizing mediastinitis, where infection spreads rapidly from the oropharynx into the chest. Chronic mediastinitis is less common and is typically associated with granulomatous diseases such as tuberculosis or histoplasmosis, or with retained foreign bodies.
Currently, most cases of mediastinitis occur as complications following cardiac surgery, especially after sternotomy. The incidence of post-surgical mediastinitis ranges from approximately 0.4% to 5%. Despite advances in surgical techniques and infection control, the incidence has remained stable due to increasing numbers of elderly and immunocompromised patients undergoing complex procedures. Risk factors include diabetes mellitus, obesity, chronic lung disease, prolonged surgical time, reoperation, and vascular comorbidities.
The pathophysiology involves invasion of the mediastinum by pathogens, leading to intense inflammation, fibrin deposition, and formation of abscesses. Infection can spread rapidly through fascial planes, creating extensive tissue damage and dead space beneath the sternum. Acute infections are usually polymicrobial. Common organisms include gram-positive bacteria such as Staphylococcus aureus and Staphylococcus epidermidis in post-surgical cases, while infections related to esophageal or oropharyngeal sources often involve gram-negative and anaerobic organisms. In severely ill patients, fungal pathogens like Candida and Aspergillus may also be involved.
Clinically, acute mediastinitis presents with fever, severe chest pain, dysphagia, and respiratory distress. Patients with esophageal perforation may also have epigastric pain. Physical findings can include a sternal click (indicating instability), crepitus due to subcutaneous air, and Hamman’s sign, a crunching sound heard over the chest. In contrast, chronic mediastinitis may initially be asymptomatic but later presents with symptoms due to compression of mediastinal structures, such as cough, dyspnea, or signs of superior vena cava syndrome.
Laboratory findings typically show leukocytosis and elevated inflammatory markers such as C-reactive protein. Blood cultures may be positive, especially in cases associated with head and neck infections. Imaging is essential for diagnosis. Chest radiographs may reveal mediastinal widening or air-fluid levels, while CT scans provide detailed visualization of fluid collections, gas, and the extent of infection. Diagnostic procedures such as CT-guided aspiration, mediastinoscopy, or thoracoscopy may be required to obtain microbiological samples.
Management of mediastinitis requires urgent and aggressive treatment. Broad-spectrum intravenous antibiotics should be initiated promptly and later tailored based on culture results. Common regimens include combinations of cephalosporins with anaerobic coverage or agents such as piperacillin-tazobactam. Coverage for MRSA may require vancomycin or linezolid. Therapy is typically prolonged, lasting several weeks.
Surgical intervention is critical and remains the cornerstone of treatment. Procedures include drainage of infected material, debridement of necrotic tissue, and sometimes more extensive approaches such as thoracotomy or video-assisted thoracic surgery. Negative pressure wound therapy may be used in postoperative cases. Supportive care, including airway management, oxygen therapy, and adequate nutrition, is essential.
The prognosis of mediastinitis is guarded, with mortality rates reaching up to 50%, especially in delayed or inadequately treated cases. Early diagnosis and prompt surgical drainage significantly improve outcomes. Complications can be severe and include sepsis, pleural empyema, sternal osteomyelitis, acute respiratory distress syndrome, thrombosis, and superior vena cava syndrome.
- Published on
Infectious Disease and Microbiology - Acute Meningitis
Acute meningitis is a rapidly developing inflammation of the meninges that typically evolves over hours to days. It may resolve spontaneously in viral cases or require urgent treatment when bacterial in origin. Despite advances in therapy, it remains a medical emergency due to its potential for rapid deterioration and severe complications.
Meningitis occurs worldwide and can affect individuals of all ages, including previously healthy people. The overall incidence in the United States is approximately 2–10 cases per 100,000 population annually, with significantly higher rates in neonates and young children. Among bacterial causes, Neisseria meningitidis is unique in its ability to cause epidemics. Vaccination programs have significantly reduced cases of Haemophilus influenzae type B meningitis.
Risk factors include extremes of age, crowded living conditions, close contact with infected individuals, head trauma, neurosurgical devices (e.g., shunts), immunosuppression, and chronic illnesses. Specific conditions predispose to certain pathogens—for example, asplenia increases risk for pneumococcal and meningococcal infections, while complement deficiencies increase susceptibility to meningococcal disease. Tick exposure may lead to Lyme meningitis.
The pathogenesis begins with colonization of the nasopharynx, followed by invasion into the bloodstream and crossing of the blood–brain barrier into the cerebrospinal fluid (CSF), where pathogens multiply. Inflammation in the subarachnoid space leads to increased intracranial pressure and neurologic dysfunction.
Etiologically, most cases are viral, particularly due to enteroviruses. However, bacterial meningitis is more severe and commonly caused by Streptococcus pneumoniae, Neisseria meningitidis, Group B Streptococcus, Listeria monocytogenes, and Haemophilus influenzae. Other pathogens include viruses (e.g., herpesviruses, HIV), spirochetes such as Treponema pallidum, and Borrelia burgdorferi.
Clinically, patients often present with fever, headache, vomiting, and altered mental status. Classical meningeal signs include nuchal rigidity, Kernig’s sign, and Brudzinski’s sign, although these may not always be present. A petechial or purpuric rash suggests meningococcal infection. Severe cases may progress to seizures, coma, or focal neurologic deficits.
Presentation may be atypical in elderly patients and neonates.
Diagnosis requires urgent evaluation. Initial laboratory tests include blood work and cultures, followed by lumbar puncture to analyze CSF. In bacterial meningitis, CSF typically shows high white blood cell count with neutrophil predominance, low glucose, and elevated protein. In viral meningitis, lymphocytes predominate, and glucose is usually normal. PCR testing improves detection of both bacterial and viral pathogens. A CT scan of the head is indicated before lumbar puncture in patients with risk factors for increased intracranial pressure or focal neurologic signs.
Treatment must be initiated immediately, often before confirmation of the causative organism. Empiric therapy typically includes a third- or fourth-generation cephalosporin combined with vancomycin, with the addition of ampicillin when Listeria is suspected. Therapy is later tailored based on culture results. Adjunctive corticosteroids may be beneficial in certain cases, particularly pneumococcal meningitis, to reduce inflammation and neurologic complications.
All patients require hospitalization for close monitoring and supportive care. Prognosis depends on factors such as age, underlying health, pathogen, and timeliness of treatment. Mortality and morbidity increase with delayed therapy, altered consciousness, or severe disease at presentation.
Complications can be severe and include seizures, hydrocephalus, brain abscess, hearing loss, cognitive impairment, paralysis, and even death. Survivors often require long-term neurologic follow-up and rehabilitation.
Acute meningitis is a rapidly developing inflammation of the meninges that typically evolves over hours to days. It may resolve spontaneously in viral cases or require urgent treatment when bacterial in origin. Despite advances in therapy, it remains a medical emergency due to its potential for rapid deterioration and severe complications.
Meningitis occurs worldwide and can affect individuals of all ages, including previously healthy people. The overall incidence in the United States is approximately 2–10 cases per 100,000 population annually, with significantly higher rates in neonates and young children. Among bacterial causes, Neisseria meningitidis is unique in its ability to cause epidemics. Vaccination programs have significantly reduced cases of Haemophilus influenzae type B meningitis.
Risk factors include extremes of age, crowded living conditions, close contact with infected individuals, head trauma, neurosurgical devices (e.g., shunts), immunosuppression, and chronic illnesses. Specific conditions predispose to certain pathogens—for example, asplenia increases risk for pneumococcal and meningococcal infections, while complement deficiencies increase susceptibility to meningococcal disease. Tick exposure may lead to Lyme meningitis.
The pathogenesis begins with colonization of the nasopharynx, followed by invasion into the bloodstream and crossing of the blood–brain barrier into the cerebrospinal fluid (CSF), where pathogens multiply. Inflammation in the subarachnoid space leads to increased intracranial pressure and neurologic dysfunction.
Etiologically, most cases are viral, particularly due to enteroviruses. However, bacterial meningitis is more severe and commonly caused by Streptococcus pneumoniae, Neisseria meningitidis, Group B Streptococcus, Listeria monocytogenes, and Haemophilus influenzae. Other pathogens include viruses (e.g., herpesviruses, HIV), spirochetes such as Treponema pallidum, and Borrelia burgdorferi.
Clinically, patients often present with fever, headache, vomiting, and altered mental status. Classical meningeal signs include nuchal rigidity, Kernig’s sign, and Brudzinski’s sign, although these may not always be present. A petechial or purpuric rash suggests meningococcal infection. Severe cases may progress to seizures, coma, or focal neurologic deficits.
Presentation may be atypical in elderly patients and neonates.
Diagnosis requires urgent evaluation. Initial laboratory tests include blood work and cultures, followed by lumbar puncture to analyze CSF. In bacterial meningitis, CSF typically shows high white blood cell count with neutrophil predominance, low glucose, and elevated protein. In viral meningitis, lymphocytes predominate, and glucose is usually normal. PCR testing improves detection of both bacterial and viral pathogens. A CT scan of the head is indicated before lumbar puncture in patients with risk factors for increased intracranial pressure or focal neurologic signs.
Treatment must be initiated immediately, often before confirmation of the causative organism. Empiric therapy typically includes a third- or fourth-generation cephalosporin combined with vancomycin, with the addition of ampicillin when Listeria is suspected. Therapy is later tailored based on culture results. Adjunctive corticosteroids may be beneficial in certain cases, particularly pneumococcal meningitis, to reduce inflammation and neurologic complications.
All patients require hospitalization for close monitoring and supportive care. Prognosis depends on factors such as age, underlying health, pathogen, and timeliness of treatment. Mortality and morbidity increase with delayed therapy, altered consciousness, or severe disease at presentation.
Complications can be severe and include seizures, hydrocephalus, brain abscess, hearing loss, cognitive impairment, paralysis, and even death. Survivors often require long-term neurologic follow-up and rehabilitation.
- Published on
Infectious Disease and Microbiology – Mesenteric Adenitis
Mesenteric adenitis is an acute inflammation of the mesenteric lymph nodes, most commonly presenting with symptoms that closely mimic acute appendicitis. It may occur as a primary condition or secondary to other diseases such as Crohn’s disease, infectious colitis, appendicitis, diverticulitis, or systemic lupus erythematosus. In many cases, it is preceded or accompanied by enterocolitis.
It is most commonly seen in children aged 5–14 years and may account for up to 8% of hospital admissions initially suspected to be appendicitis. Although many infections are subclinical or mild, outbreaks have been associated with specific food exposures, particularly undercooked pork, unpasteurized milk, and contaminated food products. Intrafamilial transmission and rare cases linked to blood transfusion have also been reported.
The condition typically results from a gastrointestinal infection, most often involving Yersinia enterocolitica. The pathogen invades Peyer’s patches in the ileum and spreads to mesenteric lymph nodes, causing inflammation. Other infectious causes include Yersinia pseudotuberculosis, Salmonella, and Mycobacterium tuberculosis. Less commonly, viral agents such as Epstein–Barr virus or adenovirus may be involved.
Patients usually present with right lower quadrant abdominal pain and fever, making differentiation from appendicitis challenging. Associated symptoms often include diarrhea and nausea, while vomiting is less common. A history of recent ingestion of high-risk foods within 1–2 weeks prior to symptom onset may provide a clue. On examination, patients may appear acutely ill with localized tenderness in the right lower abdomen. Rebound tenderness can occur but is generally less pronounced than in appendicitis. Occasionally, immune-mediated complications such as erythema nodosum or reactive arthritis may develop, especially in individuals with HLA-B27.
Laboratory findings are nonspecific and may show elevated white blood cell counts, and stool studies may reveal leukocytes in cases with diarrhea. Diagnosis is primarily supported by imaging. Abdominal ultrasound is especially useful in children, demonstrating a normal appendix along with enlarged mesenteric lymph nodes. In adults, CT scanning can confirm the presence of clustered lymph nodes near the ileocecal region while excluding appendicitis. Stool cultures for Yersinia may require special techniques such as cold enrichment, and serologic tests can assist during outbreaks.
Mesenteric adenitis is usually a self-limited condition, and treatment is primarily supportive, including hydration and symptomatic care. Antibiotics are generally not required unless there is confirmed bacterial infection with significant symptoms. In such cases, trimethoprim-sulfamethoxazole is commonly used in children, while adults may receive trimethoprim-sulfamethoxazole or ciprofloxacin. Other antibiotic options include doxycycline, ampicillin, or aminoglycosides in selected cases.
Surgical consultation may be necessary when appendicitis cannot be excluded, and laparoscopy may be performed in uncertain cases. Hospital admission is indicated for patients with severe abdominal pain, fever, rebound tenderness, hypotension, or inability to tolerate oral intake.
The prognosis is excellent, as most cases resolve without complications. However, rare complications can occur, particularly in immunocompromised individuals. These include bacteremia, septic shock, intestinal necrosis, perforation, intussusception, and metastatic infections. Post-infectious immune conditions such as reactive arthritis, uveitis, nephritis, and erythema nodosum may also develop.
Mesenteric adenitis is an acute inflammation of the mesenteric lymph nodes, most commonly presenting with symptoms that closely mimic acute appendicitis. It may occur as a primary condition or secondary to other diseases such as Crohn’s disease, infectious colitis, appendicitis, diverticulitis, or systemic lupus erythematosus. In many cases, it is preceded or accompanied by enterocolitis.
It is most commonly seen in children aged 5–14 years and may account for up to 8% of hospital admissions initially suspected to be appendicitis. Although many infections are subclinical or mild, outbreaks have been associated with specific food exposures, particularly undercooked pork, unpasteurized milk, and contaminated food products. Intrafamilial transmission and rare cases linked to blood transfusion have also been reported.
The condition typically results from a gastrointestinal infection, most often involving Yersinia enterocolitica. The pathogen invades Peyer’s patches in the ileum and spreads to mesenteric lymph nodes, causing inflammation. Other infectious causes include Yersinia pseudotuberculosis, Salmonella, and Mycobacterium tuberculosis. Less commonly, viral agents such as Epstein–Barr virus or adenovirus may be involved.
Patients usually present with right lower quadrant abdominal pain and fever, making differentiation from appendicitis challenging. Associated symptoms often include diarrhea and nausea, while vomiting is less common. A history of recent ingestion of high-risk foods within 1–2 weeks prior to symptom onset may provide a clue. On examination, patients may appear acutely ill with localized tenderness in the right lower abdomen. Rebound tenderness can occur but is generally less pronounced than in appendicitis. Occasionally, immune-mediated complications such as erythema nodosum or reactive arthritis may develop, especially in individuals with HLA-B27.
Laboratory findings are nonspecific and may show elevated white blood cell counts, and stool studies may reveal leukocytes in cases with diarrhea. Diagnosis is primarily supported by imaging. Abdominal ultrasound is especially useful in children, demonstrating a normal appendix along with enlarged mesenteric lymph nodes. In adults, CT scanning can confirm the presence of clustered lymph nodes near the ileocecal region while excluding appendicitis. Stool cultures for Yersinia may require special techniques such as cold enrichment, and serologic tests can assist during outbreaks.
Mesenteric adenitis is usually a self-limited condition, and treatment is primarily supportive, including hydration and symptomatic care. Antibiotics are generally not required unless there is confirmed bacterial infection with significant symptoms. In such cases, trimethoprim-sulfamethoxazole is commonly used in children, while adults may receive trimethoprim-sulfamethoxazole or ciprofloxacin. Other antibiotic options include doxycycline, ampicillin, or aminoglycosides in selected cases.
Surgical consultation may be necessary when appendicitis cannot be excluded, and laparoscopy may be performed in uncertain cases. Hospital admission is indicated for patients with severe abdominal pain, fever, rebound tenderness, hypotension, or inability to tolerate oral intake.
The prognosis is excellent, as most cases resolve without complications. However, rare complications can occur, particularly in immunocompromised individuals. These include bacteremia, septic shock, intestinal necrosis, perforation, intussusception, and metastatic infections. Post-infectious immune conditions such as reactive arthritis, uveitis, nephritis, and erythema nodosum may also develop.
- Published on
Infectious disease and microbiology – Mites (including chiggers)
Mites and chiggers are arthropods with four pairs of legs that infest humans, causing primarily cutaneous disease, but in some cases transmitting systemic infections such as scrub typhus.
The most important human mite is Sarcoptes scabiei, which causes scabies, while chiggers (larval forms of trombiculid mites) are responsible for intensely pruritic skin lesions and can transmit Orientia tsutsugamushi, the causative agent of scrub typhus.
Scabies has a worldwide distribution, with an estimated 300 million cases annually, and is more prevalent in tropical and resource-limited settings. Transmission occurs through close personal contact, including sexual contact, and less commonly via fomites. Household transmission rates can be high, especially in severe forms such as Norwegian (crusted) scabies, where mite burden is extensive.
Scrub typhus is endemic within the “tsutsugamushi triangle” (northern Japan to northern Australia and Afghanistan) and is commonly seen in rural areas, particularly among farmers and individuals exposed to vegetation.
The pathophysiology of scabies involves burrowing of mites into the skin, where they lay eggs. The resulting hypersensitivity reaction to the mites, eggs, and feces causes intense itching and inflammation.
In scrub typhus, the organism causes perivasculitis of small blood vessels, leading to systemic illness and potential multiorgan involvement.
Clinically, scabies presents with intensely pruritic papules and characteristic linear burrows, often found in the web spaces of fingers, wrists, and genital areas. Norwegian scabies, seen in immunocompromised individuals, presents with widespread crusted, hyperkeratotic lesions, which may resemble psoriasis and may not be itchy, leading to delayed diagnosis.
Chigger bites cause erythematous papules or pustules, commonly located around the ankles or waistline, appearing within hours of exposure.
Scrub typhus typically presents with fever, headache, and systemic symptoms, and is characterized by the presence of an eschar—a black necrotic scab—usually found in areas where clothing is tight, such as the groin or waist. Severe cases may progress to ARDS, renal failure, or hepatic dysfunction.
Diagnosis of scabies is primarily clinical, based on characteristic lesions and distribution.
Scrub typhus is diagnosed using serologic testing (IgM ELISA), with laboratory findings that may include thrombocytopenia, lymphocyte changes, and elevated liver enzymes. Chest imaging may be required if respiratory complications are suspected.
Treatment depends on the specific condition.
Scabies is treated with permethrin 5% cream, applied over the entire body and repeated after one week. Oral ivermectin is an alternative. Antihistamines may help relieve itching.
Norwegian scabies requires more aggressive and repeated therapy, often combining topical agents and systemic treatment.
Chigger bites are managed symptomatically with antihistamines or topical steroids.
Scrub typhus is treated with doxycycline, which is highly effective, while azithromycin is preferred in children and pregnant patients.
Preventive measures include good hygiene, contact precautions, and treatment of close contacts in scabies cases. For scrub typhus, protective clothing and insect repellents are essential in endemic areas.
The prognosis is generally excellent with treatment. However, untreated scrub typhus can have a mortality rate of 3–30%, especially when diagnosis is delayed.
Complications may include secondary bacterial skin infections in scabies.
In scrub typhus, severe complications include acute respiratory distress syndrome, renal failure, hepatitis, myocarditis, disseminated intravascular coagulation, meningoencephalitis, and hearing loss.
Mites and chiggers are arthropods with four pairs of legs that infest humans, causing primarily cutaneous disease, but in some cases transmitting systemic infections such as scrub typhus.
The most important human mite is Sarcoptes scabiei, which causes scabies, while chiggers (larval forms of trombiculid mites) are responsible for intensely pruritic skin lesions and can transmit Orientia tsutsugamushi, the causative agent of scrub typhus.
Scabies has a worldwide distribution, with an estimated 300 million cases annually, and is more prevalent in tropical and resource-limited settings. Transmission occurs through close personal contact, including sexual contact, and less commonly via fomites. Household transmission rates can be high, especially in severe forms such as Norwegian (crusted) scabies, where mite burden is extensive.
Scrub typhus is endemic within the “tsutsugamushi triangle” (northern Japan to northern Australia and Afghanistan) and is commonly seen in rural areas, particularly among farmers and individuals exposed to vegetation.
The pathophysiology of scabies involves burrowing of mites into the skin, where they lay eggs. The resulting hypersensitivity reaction to the mites, eggs, and feces causes intense itching and inflammation.
In scrub typhus, the organism causes perivasculitis of small blood vessels, leading to systemic illness and potential multiorgan involvement.
Clinically, scabies presents with intensely pruritic papules and characteristic linear burrows, often found in the web spaces of fingers, wrists, and genital areas. Norwegian scabies, seen in immunocompromised individuals, presents with widespread crusted, hyperkeratotic lesions, which may resemble psoriasis and may not be itchy, leading to delayed diagnosis.
Chigger bites cause erythematous papules or pustules, commonly located around the ankles or waistline, appearing within hours of exposure.
Scrub typhus typically presents with fever, headache, and systemic symptoms, and is characterized by the presence of an eschar—a black necrotic scab—usually found in areas where clothing is tight, such as the groin or waist. Severe cases may progress to ARDS, renal failure, or hepatic dysfunction.
Diagnosis of scabies is primarily clinical, based on characteristic lesions and distribution.
Scrub typhus is diagnosed using serologic testing (IgM ELISA), with laboratory findings that may include thrombocytopenia, lymphocyte changes, and elevated liver enzymes. Chest imaging may be required if respiratory complications are suspected.
Treatment depends on the specific condition.
Scabies is treated with permethrin 5% cream, applied over the entire body and repeated after one week. Oral ivermectin is an alternative. Antihistamines may help relieve itching.
Norwegian scabies requires more aggressive and repeated therapy, often combining topical agents and systemic treatment.
Chigger bites are managed symptomatically with antihistamines or topical steroids.
Scrub typhus is treated with doxycycline, which is highly effective, while azithromycin is preferred in children and pregnant patients.
Preventive measures include good hygiene, contact precautions, and treatment of close contacts in scabies cases. For scrub typhus, protective clothing and insect repellents are essential in endemic areas.
The prognosis is generally excellent with treatment. However, untreated scrub typhus can have a mortality rate of 3–30%, especially when diagnosis is delayed.
Complications may include secondary bacterial skin infections in scabies.
In scrub typhus, severe complications include acute respiratory distress syndrome, renal failure, hepatitis, myocarditis, disseminated intravascular coagulation, meningoencephalitis, and hearing loss.
- Published on
Infectious disease and microbiology – Mucormycosis
Mucormycosis is a life-threatening opportunistic fungal infection characterized by vascular invasion, thrombosis, and extensive tissue necrosis. It primarily affects immunocompromised individuals, particularly those with uncontrolled diabetes or hematologic malignancies.
The disease is relatively rare, with an estimated incidence of 1.7 cases per million people annually in the United States, but it carries a very high mortality rate. It occurs worldwide and is increasingly recognized in patients receiving antifungal prophylaxis that does not cover Mucorales (e.g., voriconazole).
Major risk factors include uncontrolled diabetes mellitus (especially with ketoacidosis), hematologic malignancies, organ transplantation, prolonged neutropenia, chronic steroid use, deferoxamine therapy, burns, trauma, and intravenous drug use. HIV infection and malnutrition also predispose to disease. Nosocomial outbreaks have been reported, particularly due to contaminated dressings.
Infection occurs through inhalation, ingestion, or direct inoculation of fungal spores. Once inside the host, Mucorales organisms invade blood vessels, leading to thrombosis, infarction, and necrosis, with rapid spread to adjacent tissues and possible hematogenous dissemination.
The most common causative organisms are molds from the order Mucorales, including Rhizopus, Mucor, Rhizomucor, Absidia, Cunninghamella, and Saksenaea. These fungi are ubiquitous in the environment, especially in soil and decaying organic matter.
Clinical presentation varies depending on the site of infection but is typically rapidly progressive and severe.
Rhinocerebral (craniofacial) mucormycosis, most common in diabetics, begins in the sinuses and spreads to the orbit and brain. Patients may present with facial pain, nasal congestion, black necrotic lesions on the palate or nasal mucosa, orbital swelling, vision loss, and altered mental status.
Pulmonary mucormycosis occurs mainly in neutropenic patients and presents with fever, progressive lung infiltrates, and poor response to antibiotics.
Gastrointestinal mucormycosis is more common in malnourished children and presents with abdominal pain, bleeding, or perforation.
Cutaneous mucormycosis occurs after trauma or burns and presents with necrotic ulcers, eschars, and tissue destruction.
Disseminated disease may involve the brain, liver, spleen, or heart and carries a very poor prognosis.
Diagnosis relies on early clinical suspicion and histopathological confirmation. Microscopy shows broad, nonseptate, irregularly branching hyphae. Culture may be performed from tissue samples, and imaging (CT or MRI) helps assess the extent of disease. Unlike other fungal infections, β-D-glucan tests are not useful.
Treatment requires urgent, aggressive management.
First-line therapy includes intravenous amphotericin B (liposomal formulation preferred due to lower toxicity).
Second-line or salvage therapy includes posaconazole, sometimes used in combination regimens.
Equally important are reversal of underlying risk factors (e.g., control of diabetes, reduction of immunosuppression) and prompt surgical debridement of necrotic tissue, which is often lifesaving.
Additional supportive therapies may include granulocyte transfusions, growth factors, hyperbaric oxygen therapy, and iron chelation strategies in selected cases.
The prognosis remains poor, especially if diagnosis is delayed. Untreated rhinocerebral disease is almost universally fatal within days, while even with treatment, survival in diabetic patients is approximately 50%. Outcomes are worse in immunocompromised individuals and in disseminated disease.
Complications include vascular thrombosis, brain abscesses, pulmonary dissemination, bowel infarction, hemorrhage, and widespread tissue destruction, often leading to death if not rapidly treated.
Mucormycosis is a life-threatening opportunistic fungal infection characterized by vascular invasion, thrombosis, and extensive tissue necrosis. It primarily affects immunocompromised individuals, particularly those with uncontrolled diabetes or hematologic malignancies.
The disease is relatively rare, with an estimated incidence of 1.7 cases per million people annually in the United States, but it carries a very high mortality rate. It occurs worldwide and is increasingly recognized in patients receiving antifungal prophylaxis that does not cover Mucorales (e.g., voriconazole).
Major risk factors include uncontrolled diabetes mellitus (especially with ketoacidosis), hematologic malignancies, organ transplantation, prolonged neutropenia, chronic steroid use, deferoxamine therapy, burns, trauma, and intravenous drug use. HIV infection and malnutrition also predispose to disease. Nosocomial outbreaks have been reported, particularly due to contaminated dressings.
Infection occurs through inhalation, ingestion, or direct inoculation of fungal spores. Once inside the host, Mucorales organisms invade blood vessels, leading to thrombosis, infarction, and necrosis, with rapid spread to adjacent tissues and possible hematogenous dissemination.
The most common causative organisms are molds from the order Mucorales, including Rhizopus, Mucor, Rhizomucor, Absidia, Cunninghamella, and Saksenaea. These fungi are ubiquitous in the environment, especially in soil and decaying organic matter.
Clinical presentation varies depending on the site of infection but is typically rapidly progressive and severe.
Rhinocerebral (craniofacial) mucormycosis, most common in diabetics, begins in the sinuses and spreads to the orbit and brain. Patients may present with facial pain, nasal congestion, black necrotic lesions on the palate or nasal mucosa, orbital swelling, vision loss, and altered mental status.
Pulmonary mucormycosis occurs mainly in neutropenic patients and presents with fever, progressive lung infiltrates, and poor response to antibiotics.
Gastrointestinal mucormycosis is more common in malnourished children and presents with abdominal pain, bleeding, or perforation.
Cutaneous mucormycosis occurs after trauma or burns and presents with necrotic ulcers, eschars, and tissue destruction.
Disseminated disease may involve the brain, liver, spleen, or heart and carries a very poor prognosis.
Diagnosis relies on early clinical suspicion and histopathological confirmation. Microscopy shows broad, nonseptate, irregularly branching hyphae. Culture may be performed from tissue samples, and imaging (CT or MRI) helps assess the extent of disease. Unlike other fungal infections, β-D-glucan tests are not useful.
Treatment requires urgent, aggressive management.
First-line therapy includes intravenous amphotericin B (liposomal formulation preferred due to lower toxicity).
Second-line or salvage therapy includes posaconazole, sometimes used in combination regimens.
Equally important are reversal of underlying risk factors (e.g., control of diabetes, reduction of immunosuppression) and prompt surgical debridement of necrotic tissue, which is often lifesaving.
Additional supportive therapies may include granulocyte transfusions, growth factors, hyperbaric oxygen therapy, and iron chelation strategies in selected cases.
The prognosis remains poor, especially if diagnosis is delayed. Untreated rhinocerebral disease is almost universally fatal within days, while even with treatment, survival in diabetic patients is approximately 50%. Outcomes are worse in immunocompromised individuals and in disseminated disease.
Complications include vascular thrombosis, brain abscesses, pulmonary dissemination, bowel infarction, hemorrhage, and widespread tissue destruction, often leading to death if not rapidly treated.
- Published on
Infectious disease and microbiology – Neuropathies, infectious
Infectious neuropathies refer to inflammation or dysfunction of peripheral nerves caused by infectious agents or their toxins, including viruses, bacteria, parasites, and toxin-mediated mechanisms. A key example is Guillain-Barré syndrome (GBS), an immune-mediated neuropathy often triggered by a preceding infection. GBS has an incidence of approximately 1.2–3 cases per 100,000 people and can occur at any age, with peaks in young adults and older individuals. Risk factors vary depending on the cause and include immunosuppression (e.g., HIV/AIDS), advanced age, and exposure to endemic infections such as Lyme disease, leprosy, or Chagas disease. Preventive measures include vaccination (e.g., zoster, rabies, tetanus) and, in specific situations like tick exposure, prophylactic antibiotics.
The pathophysiology differs by condition but often involves either direct infection of nerve tissue or immune-mediated damage. In GBS, a prior infection triggers an immune response that cross-reacts with peripheral nerve components, leading to demyelination (most common) or axonal injury. Infectious causes include viruses such as herpes simplex virus (HSV), varicella zoster virus (VZV), cytomegalovirus (CMV), and HIV; bacteria such as Borrelia burgdorferi (Lyme disease) and Mycobacterium leprae (leprosy); parasites like Trypanosoma cruzi; and toxins from organisms such as Clostridium botulinum and Corynebacterium diphtheriae. Additionally, many cases of GBS are preceded by infections like Campylobacter jejuni, respiratory viruses, or gastrointestinal illnesses.
Clinical presentation depends on the underlying cause. Viral neuropathies often present with pain and dermatomal rashes, as seen in herpes zoster, or progressive sensory and motor deficits, as in CMV or HIV-related neuropathies. Bacterial causes such as Lyme disease may produce cranial nerve palsies, meningitis, or radiculopathy, while leprosy leads to sensory loss and nerve thickening. Toxin-mediated neuropathies have distinctive features, such as descending paralysis in botulism or muscle spasms in tetanus. In contrast, GBS typically begins with ascending symmetric weakness starting in the lower limbs, progressing over days to weeks and potentially involving respiratory muscles and autonomic dysfunction.
Diagnosis relies on clinical evaluation supported by laboratory and imaging studies. Tests may include detection of viral DNA (e.g., CMV in cerebrospinal fluid), serologic testing for Lyme disease, toxin identification in suspected botulism, and cerebrospinal fluid analysis in GBS, which classically shows elevated protein with normal cell count. Imaging such as MRI may demonstrate nerve root enhancement, while nerve conduction studies help assess the extent of nerve involvement.
Management is directed at the underlying cause. Antiviral therapy (e.g., acyclovir for HSV/VZV, ganciclovir for CMV) is used for viral infections, while bacterial causes like Lyme disease are treated with doxycycline or ceftriaxone. Toxin-mediated conditions require antitoxins and supportive care. For GBS, early treatment with plasmapheresis or intravenous immunoglobulin (IVIG) is essential to reduce disease severity and duration. Supportive care, including monitoring for respiratory failure, managing autonomic instability, and rehabilitation, plays a critical role in recovery.
Complications can be significant, particularly in GBS, where patients may experience residual neurologic deficits, recurrence, or prolonged disability. Early recognition and prompt management are crucial to improving outcomes and reducing long-term morbidity.
Infectious neuropathies refer to inflammation or dysfunction of peripheral nerves caused by infectious agents or their toxins, including viruses, bacteria, parasites, and toxin-mediated mechanisms. A key example is Guillain-Barré syndrome (GBS), an immune-mediated neuropathy often triggered by a preceding infection. GBS has an incidence of approximately 1.2–3 cases per 100,000 people and can occur at any age, with peaks in young adults and older individuals. Risk factors vary depending on the cause and include immunosuppression (e.g., HIV/AIDS), advanced age, and exposure to endemic infections such as Lyme disease, leprosy, or Chagas disease. Preventive measures include vaccination (e.g., zoster, rabies, tetanus) and, in specific situations like tick exposure, prophylactic antibiotics.
The pathophysiology differs by condition but often involves either direct infection of nerve tissue or immune-mediated damage. In GBS, a prior infection triggers an immune response that cross-reacts with peripheral nerve components, leading to demyelination (most common) or axonal injury. Infectious causes include viruses such as herpes simplex virus (HSV), varicella zoster virus (VZV), cytomegalovirus (CMV), and HIV; bacteria such as Borrelia burgdorferi (Lyme disease) and Mycobacterium leprae (leprosy); parasites like Trypanosoma cruzi; and toxins from organisms such as Clostridium botulinum and Corynebacterium diphtheriae. Additionally, many cases of GBS are preceded by infections like Campylobacter jejuni, respiratory viruses, or gastrointestinal illnesses.
Clinical presentation depends on the underlying cause. Viral neuropathies often present with pain and dermatomal rashes, as seen in herpes zoster, or progressive sensory and motor deficits, as in CMV or HIV-related neuropathies. Bacterial causes such as Lyme disease may produce cranial nerve palsies, meningitis, or radiculopathy, while leprosy leads to sensory loss and nerve thickening. Toxin-mediated neuropathies have distinctive features, such as descending paralysis in botulism or muscle spasms in tetanus. In contrast, GBS typically begins with ascending symmetric weakness starting in the lower limbs, progressing over days to weeks and potentially involving respiratory muscles and autonomic dysfunction.
Diagnosis relies on clinical evaluation supported by laboratory and imaging studies. Tests may include detection of viral DNA (e.g., CMV in cerebrospinal fluid), serologic testing for Lyme disease, toxin identification in suspected botulism, and cerebrospinal fluid analysis in GBS, which classically shows elevated protein with normal cell count. Imaging such as MRI may demonstrate nerve root enhancement, while nerve conduction studies help assess the extent of nerve involvement.
Management is directed at the underlying cause. Antiviral therapy (e.g., acyclovir for HSV/VZV, ganciclovir for CMV) is used for viral infections, while bacterial causes like Lyme disease are treated with doxycycline or ceftriaxone. Toxin-mediated conditions require antitoxins and supportive care. For GBS, early treatment with plasmapheresis or intravenous immunoglobulin (IVIG) is essential to reduce disease severity and duration. Supportive care, including monitoring for respiratory failure, managing autonomic instability, and rehabilitation, plays a critical role in recovery.
Complications can be significant, particularly in GBS, where patients may experience residual neurologic deficits, recurrence, or prolonged disability. Early recognition and prompt management are crucial to improving outcomes and reducing long-term morbidity.
- Published on
Infectious disease and microbiology – Necrotizing soft-tissue infections
Necrotizing soft-tissue infections (NSTIs) are rapidly progressive, life-threatening infections that involve the fascia and may extend to muscles, leading to extensive tissue destruction. They usually arise after a break in the skin, such as trauma, surgery, or even minor events like insect bites, although in many cases no clear initiating factor is identified. Clinically, they may present as necrotizing cellulitis, necrotizing fasciitis, or pyomyositis, and they are associated with high mortality rates exceeding 20%, often reaching around one-third of cases.
The incidence of NSTIs has been increasing, and although still uncommon, most clinicians will encounter at least one case during their practice. Risk factors include immunocompromised states, particularly diabetes mellitus and peripheral vascular disease, as well as obesity, chronic liver or renal disease, HIV infection, intravenous drug use, older age, and frequent hospitalizations. Certain populations, such as athletes or institutionalized individuals, are more prone to infections caused by community-associated MRSA.
Pathophysiologically, bacteria invade subcutaneous tissues and spread rapidly along fascial planes. The production of toxins and enzymes leads to local ischemia, impaired immune response, and widespread necrosis, allowing the infection to advance quickly. Most cases are polymicrobial (Type 1), involving a mixture of aerobic and anaerobic organisms, while others are monomicrobial (Types 2 and 3), commonly caused by Group A Streptococcus, Staphylococcus aureus, or Clostridium species.
Clinically, early symptoms may appear deceptively mild, with pain, erythema, swelling, and tachycardia, but the hallmark is pain out of proportion to physical findings. As the disease progresses, patients develop skin discoloration, bullae, crepitus, anesthesia, and systemic signs such as fever, hypotension, and shock, often rapidly progressing to sepsis and multi-organ failure. Diagnosis is primarily clinical, and urgent surgical exploration remains the gold standard, as delays can be fatal. Laboratory findings and scoring systems such as the LRINEC score may support suspicion, while imaging (CT or MRI) can reveal fascial thickening or gas in tissues but should not delay treatment.
Management requires immediate and aggressive intervention, combining broad-spectrum intravenous antibiotics with early surgical debridement, which is the most critical factor in reducing mortality. Empiric antibiotic therapy should cover gram-positive, gram-negative, and anaerobic organisms, with adjustments based on culture results. Repeated surgical exploration is often necessary, and in severe cases, amputation may be required. Patients typically require intensive care support, including fluid resuscitation, hemodynamic stabilization, and nutritional support.
Despite advances in management, prognosis remains serious. Mortality has improved with early recognition and aggressive treatment but remains high, and survivors often face significant morbidity. Complications include sepsis, acute respiratory distress syndrome, renal failure, nosocomial infections, and limb loss, highlighting the importance of prompt diagnosis and multidisciplinary management.
Necrotizing soft-tissue infections (NSTIs) are rapidly progressive, life-threatening infections that involve the fascia and may extend to muscles, leading to extensive tissue destruction. They usually arise after a break in the skin, such as trauma, surgery, or even minor events like insect bites, although in many cases no clear initiating factor is identified. Clinically, they may present as necrotizing cellulitis, necrotizing fasciitis, or pyomyositis, and they are associated with high mortality rates exceeding 20%, often reaching around one-third of cases.
The incidence of NSTIs has been increasing, and although still uncommon, most clinicians will encounter at least one case during their practice. Risk factors include immunocompromised states, particularly diabetes mellitus and peripheral vascular disease, as well as obesity, chronic liver or renal disease, HIV infection, intravenous drug use, older age, and frequent hospitalizations. Certain populations, such as athletes or institutionalized individuals, are more prone to infections caused by community-associated MRSA.
Pathophysiologically, bacteria invade subcutaneous tissues and spread rapidly along fascial planes. The production of toxins and enzymes leads to local ischemia, impaired immune response, and widespread necrosis, allowing the infection to advance quickly. Most cases are polymicrobial (Type 1), involving a mixture of aerobic and anaerobic organisms, while others are monomicrobial (Types 2 and 3), commonly caused by Group A Streptococcus, Staphylococcus aureus, or Clostridium species.
Clinically, early symptoms may appear deceptively mild, with pain, erythema, swelling, and tachycardia, but the hallmark is pain out of proportion to physical findings. As the disease progresses, patients develop skin discoloration, bullae, crepitus, anesthesia, and systemic signs such as fever, hypotension, and shock, often rapidly progressing to sepsis and multi-organ failure. Diagnosis is primarily clinical, and urgent surgical exploration remains the gold standard, as delays can be fatal. Laboratory findings and scoring systems such as the LRINEC score may support suspicion, while imaging (CT or MRI) can reveal fascial thickening or gas in tissues but should not delay treatment.
Management requires immediate and aggressive intervention, combining broad-spectrum intravenous antibiotics with early surgical debridement, which is the most critical factor in reducing mortality. Empiric antibiotic therapy should cover gram-positive, gram-negative, and anaerobic organisms, with adjustments based on culture results. Repeated surgical exploration is often necessary, and in severe cases, amputation may be required. Patients typically require intensive care support, including fluid resuscitation, hemodynamic stabilization, and nutritional support.
Despite advances in management, prognosis remains serious. Mortality has improved with early recognition and aggressive treatment but remains high, and survivors often face significant morbidity. Complications include sepsis, acute respiratory distress syndrome, renal failure, nosocomial infections, and limb loss, highlighting the importance of prompt diagnosis and multidisciplinary management.
